{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T11:33:40Z","timestamp":1781782420773,"version":"3.54.5"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2002,6,1]],"date-time":"2002-06-01T00:00:00Z","timestamp":1022889600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2002,6,1]],"date-time":"2002-06-01T00:00:00Z","timestamp":1022889600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2002,6]]},"DOI":"10.1023\/a:1015339018181","type":"journal-article","created":{"date-parts":[[2002,12,28]],"date-time":"2002-12-28T18:08:17Z","timestamp":1041098897000},"page":"1362-1368","source":"Crossref","is-referenced-by-count":12,"title":["Effect of Cyclosporine in a Murine Model of Experimental Colitis"],"prefix":"10.1007","volume":"47","author":[{"given":"Marko","family":"Bani\u0107","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Branimir","family":"Ani\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomislav","family":"Brki\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neven","family":"Ljubici\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanja","family":"Plesko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Csaba","family":"Dohoczky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damir","family":"Erceg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mladen","family":"Petrovecki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Igor","family":"Stipanci\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivo","family":"Rotkvi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"375536_CR1","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1056\/NEJM199905063401804","volume":"340","author":"DH Present","year":"1999","unstructured":"Present DH, Rutgeerts P, Targan S, Mayer L, van Hogezand RA, Podolsky DK, Sands BE, Braakman T, DeWoody KL, Schaible TF, van Deventer SJ: Infliximab for treatment of fistulas in patients with Crohn's disease. N Engl J Med 340:1398\u20131405, 1999","journal-title":"N Engl J Med"},{"key":"375536_CR2","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1016\/S0016-5085(99)70276-3","volume":"117","author":"ED Ehrenpreis","year":"1999","unstructured":"Ehrenpreis ED, Kane SV, Cohen LB, Cohen RD, Hanauer SB: Thalidomide therapy for patients with refractory Crohn's disease: An open label trial. Gastroenterology 117:1271\u20131277, 1999","journal-title":"Gastroenterology"},{"key":"375536_CR3","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1016\/S0016-5085(99)70277-5","volume":"117","author":"EA Vasiliauskas","year":"1999","unstructured":"Vasiliauskas EA, Kam LY, Abreu-Martin MT, Hassard PV, Papadakis KA, Yang H, Zeldis JB, Targan SR. An open-label pilot study of low-dose thalidomide in chronically active, steroid-dependent Crohn's disease. Gastroenterology 117:1278\u20131287, 1999","journal-title":"Gastroenterology"},{"key":"375536_CR4","doi-asserted-by":"crossref","first-page":"849","DOI":"10.3109\/00365529309103124","volume":"28","author":"J Brynskow","year":"1993","unstructured":"Brynskow J: Cyclosporine for inflammatory bowel disease: Mechanisms and possible actions. Scand J Gastroenterol 28:849\u2013857, 1993","journal-title":"Scand J Gastroenterol"},{"key":"375536_CR5","first-page":"97","volume-title":"Inhibition and Modulation of gastrointestinal inflammation","author":"W Strober","year":"1998","unstructured":"Strober W, Ehrhardt RO, Ludviksson BR: Inflammatory bowel diseases: A breakdown of central and peripheral immunological homeostasis. In Inhibition and Modulation of gastrointestinal inflammation. Falk Symposium 104. A Stallmach, M Zeitz, W Strober, TT MacDonald, H Lochs (eds). Dordrecht, Kluwer Academic Publishers, 1998, pp 97\u2013110"},{"key":"375536_CR6","doi-asserted-by":"crossref","first-page":"184","DOI":"10.3109\/00365529208999946","volume":"27","author":"T Brki?","year":"1992","unstructured":"Brki? T, Bani? M, Ani? B, Grabarevi? \u017d, Rotkvi? I, Artukovi? B, Duvnjak M, Sikiri? P, Troskot B, Hernandez DE: A model of inflammatory bowel disease induced by 2,4-dinitrofluorobenzene in previously sensitized BALB\/c mice. Scand J Gastroenterol 27:184\u2013188, 1992","journal-title":"Scand J Gastroenterol"},{"key":"375536_CR7","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/j.1365-2036.1993.tb00091.x","volume":"7","author":"M Bani?","year":"1993","unstructured":"Bani? M, Brki? T, Ani? B, Rotkvi? I, Grabarevi? \u017d, Duvnjak M, Troskot B, Mihatov \u0160: Effect of methylprednisolone on small bowel, spleen and liver changes in murine model of inflammatory bowel disease. Aliment Pharmacol Ther 7:201\u2013206, 1993","journal-title":"Aliment Pharmacol Ther"},{"key":"375536_CR8","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1093\/clinchem\/36.10.1841","volume":"36","author":"LM Shaw","year":"1990","unstructured":"Shaw LM, Yatscoff RW, Bowers LD: Canadian consensus meeting on cyclosporine monitoring: report of the consensus panel. Clin Chem 36:1841\u20131846, 1990","journal-title":"Clin Chem"},{"key":"375536_CR9","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1136\/gut.25.1.32","volume":"25","author":"WS Selby","year":"1984","unstructured":"Selby WS, Janossy G, Boffil M, Jewell DP: Intestinal lymphocyte subpopulations in inflammatory bowel disease by immunohistochemical and cell isolation techniques. Gut 25:32\u201340, 1984","journal-title":"Gut"},{"key":"375536_CR10","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1136\/gut.31.5.539","volume":"31","author":"J Vilaseca","year":"1990","unstructured":"Vilaseca J, Salas A, Guarner F, Rodrigez R, Martinez M, Malagelada J-R: Dietary fish oil reduces progression of chronic inflammatory lesions in a rat model of granulomatous colitis. Gut 31:539\u2013544, 1990","journal-title":"Gut"},{"key":"375536_CR11","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S0022-3565(25)24349-X","volume":"272","author":"M Velja?a","year":"1995","unstructured":"Velja?a M, Lesch CA, Pllana R, Sanchez B, Chan K, Guglieta A: BPC-15 reduces trinitrobenzene sulfonic acid-induced colonic damage in rats. JPET 272:417\u2013422, 1995","journal-title":"JPET"},{"key":"375536_CR12","volume-title":"Basic and Clinical Biostatistics","author":"B Dawson-Saunders","year":"1994","unstructured":"Dawson-Saunders B, Trapp RG: Basic and Clinical Biostatistics. London, Prentice-Hall, 1994"},{"key":"375536_CR13","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/0016-5085(91)90524-O","volume":"101","author":"K Fukushima","year":"1991","unstructured":"Fukushima K, Masuda T, Ohtani H, Sasaki I, Funayama Y, Matsuno S, Nagura H: Immunohistochemical characterization, distribution and ultrastructure of lymphocyte bearing T-cell receptor gamma\/delta in inflammatory bowel disease. Gastroenterology 101:670\u2013678, 1991","journal-title":"Gastroenterology"},{"key":"375536_CR14","doi-asserted-by":"crossref","first-page":"529","DOI":"10.3109\/00365529209000116","volume":"27","author":"HS Kim","year":"1992","unstructured":"Kim HS, Berstad A: Experimental colitis in animal models. Scand J Gastroenterol 27:529\u2013537, 1992","journal-title":"Scand J Gastroenterol"},{"key":"375536_CR15","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1016\/0016-5085(95)90599-5","volume":"109","author":"CO Elson","year":"1995","unstructured":"Elson CO, Sartor RB, Tennyson GS, Riddell RH: Experimental models of inflammatory bowel disease. Gastroenterology 109:1344\u20131367, 1995","journal-title":"Gastroenterology"},{"key":"375536_CR16","first-page":"1007","volume-title":"Mucosal Immunology","author":"CO Elson","year":"1999","unstructured":"Elson CO: Experimental models of intestinal inflammation. New insights into mechanisms of mucosal homeostasis: In PL Ogra, J Mestecky, ME Lamm, W Strober, J Bienenstock, JR McGhee (eds). Mucosal Immunology. San Diego, Academic Press, 1999, pp 1007\u20131024"},{"key":"375536_CR17","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0016-5085(89)90760-9","volume":"96","author":"JL Wallace","year":"1989","unstructured":"Wallace JL, MacNaughton WK, Morris GP, Beck PL: Inhibition of leukotriene synthesis markedly accelerates healing in a rat model of inflammatory bowel disease. Gastroenterology 96:29\u201336, 1989","journal-title":"Gastroenterology"},{"key":"375536_CR18","first-page":"171","volume":"239","author":"A Higa","year":"1993","unstructured":"Higa A, McKnight GW, Wallace JL: Attenuation of epithelial injury in acute experimental colitis by immunomodulators 239:171\u2013176, 1993","journal-title":"Attenuation of epithelial injury in acute experimental colitis by immunomodulators"},{"key":"375536_CR19","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/S0016-5085(89)80079-4","volume":"96","author":"GP Morris","year":"1989","unstructured":"Morris, GP, Beck PL, Herridge MS, Depew WT, Sewczuk MR, Wallace JL: Hapten-induced model of chronic inflammation and ulceration in rat colon. Gastroenterology 96:795\u2013803, 1989","journal-title":"Gastroenterology"},{"key":"375536_CR20","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1111\/1523-1747.ep12460866","volume":"90","author":"H Suya","year":"1988","unstructured":"Suya H, Fujioka A, Pincelli C, Fukuyama K, Epstein WL: Skin granuloma in mice immunosupressed by cyclosporine. J Invest Dermatol 90:430\u2013433, 1988","journal-title":"J Invest Dermatol"},{"key":"375536_CR21","first-page":"97","volume-title":"Inhibition and Modulation of Gastrointestinal Inflammation","author":"J Braunstein","year":"1998","unstructured":"Braunstein J, Autschbach F, Sido B, Nebl G, Schroeder A, Samstag Y, Meuer SC: Insensitivity towards inhibition by cyclosporine A, rapamycin and tacrolimus in human intestinal lamina propria T-lymphocytes. In Inhibition and Modulation of Gastrointestinal Inflammation. Falk Symposium 104. A Stallmach, M Zeitz, W Strober, TT MacDonald, H Lochs (eds). Dordrecht, Kluwer Academic Publishers, 1998, pp 97\u2013110"},{"key":"375536_CR22","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1056\/NEJM199406303302601","volume":"330","author":"S Lichtiger","year":"1994","unstructured":"Lichtiger S, Present DH, Kornbluth A, Gelernt I, Bauer J, Galler G, Michelassi F, Hanauer S: Cyclosporine in severe ulcerative colitis refractory to steroid therapy. N Engl J Med 330:1841\u20131845, 1994","journal-title":"N Engl J Med"},{"key":"375536_CR23","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1056\/NEJM199406303302602","volume":"330","author":"BG Feagan","year":"1994","unstructured":"Feagan BG, McDonald JWD, Rochon J, Laupacis A, Fedorak RN, Kinnear D, Saibil F, Groll A, Archambault A, Gillies R, Valberg B, Irvine J, for Canadian Crohn's Relapse Prevention Trial Investigators: Low-dose cyclosporine for the treatment of Crohn's disease. N Engl J Med 330:1846\u20131851, 1994","journal-title":"N Engl J Med"},{"key":"375536_CR24","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1097\/00054725-199503000-00006","volume":"1","author":"WJ Sandborn","year":"1995","unstructured":"Sandborn WJ: A critical review of cyclosporine therapy in inflammatory bowel disease. Bowel Dis 1:48\u201363, 1995","journal-title":"Bowel Dis"},{"key":"375536_CR25","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1084\/jem.164.5.1615","volume":"164","author":"R Sorokin","year":"1986","unstructured":"Sorokin R, Kimura H, Schroeder K, Wilson DH, Wilson DB: Cyclosporine-induced autoimmunity. Conditions for expressing disease, requirement for intact thymus and potency estimates of autoimmune lymphocytes in drug treated rats. J Exp Med 164:1615\u20131625, 1986","journal-title":"J Exp Med"},{"key":"375536_CR26","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.4049\/jimmunol.151.2.1039","volume":"151","author":"PR Bucy","year":"1993","unstructured":"Bucy PR, Xu XY, Li J, Huang GQ: Cyclosporine A-induced autoimmune disease in mice. J Immunol 151:1039\u20131050, 1993","journal-title":"J Immunol"},{"key":"375536_CR27","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/0167-5699(96)80577-9","volume":"17","author":"THM Ottenhof","year":"1996","unstructured":"Ottenhof THM: Selective modulation of T-cell responses in autoimmunitiy and cancer. Immunol Today 17:54\u201355, 1996","journal-title":"Immunol Today"},{"key":"375536_CR28","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1002\/j.1552-4604.1991.tb01890.x","volume":"31","author":"WJ Sandborn","year":"1991","unstructured":"Sandborn WJ, Stron RM, Forland SC, Chase RE, Cutler RE: The pharmacokinetics and colon tissue concentrations of cyclosporine after IV, oral and enema administration. J Clin Pharmacol 31:76\u201380, 1991","journal-title":"J Clin Pharmacol"},{"key":"375536_CR29","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/0016-5085(93)90262-B","volume":"104","author":"C Gurbindo","year":"1993","unstructured":"Gurbindo C, Russo P, Sabbah S, Lohoues MJ, Seisman E: Interleukin-2 activity of colonic lamina propria mononuclear cells in a rat model of experimental colitis. Gastroenterology 104:964\u2013972, 1993","journal-title":"Gastroenterology"},{"key":"375536_CR30","unstructured":"Brynskow J: Cyclosporine\/Tacrolimus in Crohn's disease: acute and chronic. Falk symposium 119. Immunosuppression in inflammatory bowel disease\u2014standards\u2014new developments\u2014future trends. Abstract Book, 2000, p 38"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1015339018181.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1023\/A:1015339018181\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1015339018181.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,29]],"date-time":"2025-07-29T02:55:02Z","timestamp":1753757702000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1023\/A:1015339018181"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,6]]},"references-count":30,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2002,6]]}},"alternative-id":["375536"],"URL":"https:\/\/doi.org\/10.1023\/a:1015339018181","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,6]]}}}